MY125870A
(en)
*
|
1997-07-25 |
2006-08-30 |
Alza Corp |
Osmotic delivery system flow modulator apparatus and method
|
EP1041968B1
(en)
*
|
1997-12-29 |
2004-03-03 |
Alza Corporation |
Osmotic delivery system with membrane plug retention mechanism
|
ATE234603T1
(en)
|
1998-12-31 |
2003-04-15 |
Alza Corp |
OSMOTIC ADMINISTRATION SYSTEM WITH SPACE-SAVING PISTONS
|
US7258869B1
(en)
*
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
US7919109B2
(en)
|
1999-02-08 |
2011-04-05 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
WO2001045675A2
(en)
*
|
1999-12-21 |
2001-06-28 |
Alza Corporation |
Valve for osmotic devices
|
US7163688B2
(en)
*
|
2001-06-22 |
2007-01-16 |
Alza Corporation |
Osmotic implant with membrane and membrane retention means
|
US20100311701A1
(en)
*
|
2002-02-15 |
2010-12-09 |
Transform Pharmaceuticals, Inc |
Pharmaceutical Co-Crystal Compositions
|
US7927613B2
(en)
*
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
US7790905B2
(en)
*
|
2002-02-15 |
2010-09-07 |
Mcneil-Ppc, Inc. |
Pharmaceutical propylene glycol solvate compositions
|
CA2477923C
(en)
*
|
2002-03-01 |
2021-02-23 |
University Of South Florida |
Multiple-component solid phases containing at least one active pharmaceutical ingredient
|
JP2005533782A
(en)
*
|
2002-06-17 |
2005-11-10 |
アルザ コーポレイション |
An osmotic delivery system having an engine with fast extruding force and zero order including an osmotic agent dispersed in a fluid vehicle
|
MXPA05000232A
(en)
*
|
2002-06-21 |
2005-06-17 |
Transform Pharmaceuticals Inc |
Pharmaceutical compositions with improved dissolution.
|
ES2295642T3
(en)
|
2002-06-26 |
2008-04-16 |
Intarcia Therapeutics, Inc. |
EFFICIENT VOLUME PISTON OF MINIMUM OCCUPATION FOR MEDICINAL ADMINISTRATION SYSTEMS.
|
US7014636B2
(en)
*
|
2002-11-21 |
2006-03-21 |
Alza Corporation |
Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel
|
KR20050088196A
(en)
*
|
2002-12-19 |
2005-09-02 |
알자 코포레이션 |
Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device
|
US7731947B2
(en)
*
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
EP2339328A3
(en)
|
2002-12-30 |
2011-07-13 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of celecoxib
|
US8183290B2
(en)
*
|
2002-12-30 |
2012-05-22 |
Mcneil-Ppc, Inc. |
Pharmaceutically acceptable propylene glycol solvate of naproxen
|
AU2003272270A1
(en)
|
2003-02-28 |
2004-09-28 |
The Regents Of The University Of Michigan |
Pharmaceutical co-crystal compositions of drugs such as carbamazeptine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
CN1767815A
(en)
|
2003-03-31 |
2006-05-03 |
阿尔萨公司 |
Non-aqueous single phase vehicles and formulations utilizing such vehicles
|
KR20060017749A
(en)
|
2003-03-31 |
2006-02-27 |
알자 코포레이션 |
Osmotic pump with means for dissipating internal pressure
|
CA2520766A1
(en)
*
|
2003-03-31 |
2004-10-21 |
Alza Corporation |
Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems
|
US20040214893A1
(en)
*
|
2003-04-11 |
2004-10-28 |
Matthew Peterson |
Gabapentin compositions
|
JP2007502329A
(en)
|
2003-05-23 |
2007-02-08 |
トランスフォーム・ファーマシューティカルズ・インコーポレイテッド |
Sertraline composition
|
CA2540059C
(en)
|
2003-09-26 |
2013-08-06 |
Alza Corporation |
Controlled release formulations exhibiting an ascending rate of release
|
AU2004314693B2
(en)
|
2003-09-26 |
2011-04-07 |
Alza Corporation |
Drug coating providing high drug loading and methods for providing the same
|
JP5670609B2
(en)
*
|
2003-09-26 |
2015-02-18 |
アルザ・コーポレーシヨン |
OROS push-stick for controlled delivery of active ingredients
|
CA2540056C
(en)
*
|
2003-09-26 |
2015-03-24 |
Alza Corporation |
Controlled release formulations of opioid and nonopioid analgesics
|
EP1682099A2
(en)
|
2003-09-30 |
2006-07-26 |
ALZA Corporation |
Osmotically driven active agent delivery device providing an ascending release profile
|
JP2007509703A
(en)
|
2003-10-31 |
2007-04-19 |
アルザ・コーポレーシヨン |
Osmotic pump with self-holding, quick start membrane plug
|
US20050113410A1
(en)
*
|
2003-11-03 |
2005-05-26 |
Mark Tawa |
Pharmaceutical salts of zafirlukast
|
CN1874763A
(en)
*
|
2003-11-06 |
2006-12-06 |
阿尔扎公司 |
Modular imbibition rate reducer for use with implantable osmotic pump
|
EP2428516A1
(en)
|
2003-11-19 |
2012-03-14 |
Metabasis Therapeutics, Inc. |
Novel phosphorus-containing thyromimetics
|
WO2005092065A2
(en)
*
|
2004-03-25 |
2005-10-06 |
Transform Pharmaceuticals, Inc. |
Novel tricyclic compounds and related methods of treatment
|
JP2007531145A
(en)
*
|
2004-03-31 |
2007-11-01 |
コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ |
Method and system for transferring a budget in a limited budget usage approach
|
US20050266087A1
(en)
*
|
2004-05-25 |
2005-12-01 |
Gunjan Junnarkar |
Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
|
JP5017103B2
(en)
*
|
2004-06-17 |
2012-09-05 |
トランスフオーム・フアーマシユーチカルズ・インコーポレーテツド |
Pharmaceutical co-crystal composition and related methods of use
|
CN101010114B
(en)
|
2004-08-27 |
2010-05-26 |
皇家飞利浦电子股份有限公司 |
Electronically and remotely controlled pill and system for delivering at least one medicament
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
US8779175B2
(en)
|
2004-10-25 |
2014-07-15 |
Synthonics, Inc. |
Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
|
US20060160783A1
(en)
*
|
2004-12-30 |
2006-07-20 |
Transform Pharmaceuticals, Inc. |
Novel omeprazole forms and related methods
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
EP2361630A1
(en)
*
|
2005-02-03 |
2011-08-31 |
Intarcia Therapeutics, Inc |
Implantable drug delivery device comprising particles and an osmotic pump
|
US7959938B2
(en)
|
2005-03-15 |
2011-06-14 |
Intarcia Therapeutics, Inc. |
Polyoxaester suspending vehicles for use with implantable delivery systems
|
WO2007005680A1
(en)
*
|
2005-06-30 |
2007-01-11 |
Alza Corporation |
Osmotic intraosseous drug delivery system
|
US20070027105A1
(en)
*
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
US7931620B2
(en)
*
|
2006-02-01 |
2011-04-26 |
Roche Diagnostics International Ag |
Self-sealing connection for housing shells of an administering device
|
CN101432032A
(en)
*
|
2006-04-28 |
2009-05-13 |
皇家飞利浦电子股份有限公司 |
Osmotic pump with at least one chargeable material
|
JP5143131B2
(en)
|
2006-05-30 |
2013-02-13 |
インターシア セラピューティクス,インコーポレイティド |
Two-piece internal channel flow modulator for osmotic delivery system
|
PL2359808T3
(en)
*
|
2006-08-09 |
2013-10-31 |
Intarcia Therapeutics Inc |
Osmotic delivery systems and piston assemblies
|
US9114133B2
(en)
|
2006-08-25 |
2015-08-25 |
U.S. Dept. Of Veterans Affairs |
Method of improving diastolic dysfunction
|
US8617143B2
(en)
*
|
2006-12-07 |
2013-12-31 |
The Regents Of The University Of California |
Therapeutic agent delivery systems and devices
|
KR20180099916A
(en)
|
2007-02-09 |
2018-09-05 |
메타베이시스 테라퓨틱스, 인크. |
Novel antagonists of the glucagon receptor
|
MX2009011123A
(en)
*
|
2007-04-23 |
2009-11-02 |
Intarcia Therapeutics Inc |
Suspension formulations of insulinotropic peptides and uses thereof.
|
US20090028941A1
(en)
*
|
2007-07-27 |
2009-01-29 |
Depomed, Inc. |
Pulsatile gastric retentive dosage forms
|
CA2695583A1
(en)
|
2007-08-13 |
2009-02-19 |
Metabasis Therapeutics, Inc. |
Novel activators of glucokinase
|
US9226907B2
(en)
|
2008-02-01 |
2016-01-05 |
Abbvie Inc. |
Extended release hydrocodone acetaminophen and related methods and uses thereof
|
EP2240155B1
(en)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
EP3153501B1
(en)
|
2008-08-13 |
2018-11-28 |
Metabasis Therapeutics, Inc. |
Glucagon antagonists
|
CN106880596A
(en)
*
|
2008-10-15 |
2017-06-23 |
精达制药公司 |
Highly enriched drug particles, preparation, supensoid agent and its application
|
BRPI1006765A2
(en)
|
2009-04-07 |
2019-03-26 |
Koninl Philips Electronics Nv |
ingestible capsule for drug release
|
US10046109B2
(en)
|
2009-08-12 |
2018-08-14 |
Progenity, Inc. |
Drug delivery device with compressible drug reservoir
|
NZ598686A
(en)
|
2009-09-28 |
2014-05-30 |
Intarcia Therapeutics Inc |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
AU2011237592B2
(en)
|
2010-04-08 |
2016-10-27 |
Emory University |
Substituted androst-4-ene diones
|
CA2807656A1
(en)
|
2010-08-30 |
2012-03-08 |
SinuSys Corporation |
Devices and methods for dilating a paranasal sinus opening and for treating sinusitis
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
WO2012129237A2
(en)
|
2011-03-20 |
2012-09-27 |
Trustees Of Boston University |
Therapeutic agent for emphysema and copd
|
JP5992991B2
(en)
*
|
2011-03-24 |
2016-09-14 |
メディメトリクス ペルソナリズド ドルグ デリヴェリー ベー ヴェ |
Swallowable medical capsule
|
ITFI20110114A1
(en)
|
2011-05-31 |
2012-12-01 |
Scuola Superiore Di Studi Universit Arie Di Perfe |
ROBOTIC PLATFORM FOR MINING-INVASIVE SURGERY
|
US20140227293A1
(en)
|
2011-06-30 |
2014-08-14 |
Trustees Of Boston University |
Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
|
US20130090633A1
(en)
*
|
2011-10-07 |
2013-04-11 |
University Of Southern California |
Osmotic patch pump
|
TWI615155B
(en)
*
|
2011-11-01 |
2018-02-21 |
拜耳股份有限公司 |
Osmotically active vaginal delivery system
|
US9138569B2
(en)
|
2012-02-29 |
2015-09-22 |
SinuSys Corporation |
Devices and methods for dilating a paranasal sinus opening and for treating sinusitis
|
US9737364B2
(en)
|
2012-05-14 |
2017-08-22 |
Vanderbilt University |
Local magnetic actuation of surgical devices
|
CA2873967A1
(en)
|
2012-05-21 |
2013-11-28 |
Bayer Pharma Aktiengesellschaft |
Substituted benzothienopyrimidines
|
US9826904B2
(en)
|
2012-09-14 |
2017-11-28 |
Vanderbilt University |
System and method for detecting tissue surface properties
|
US20140081169A1
(en)
*
|
2012-09-17 |
2014-03-20 |
Vanderbilt University |
System and method of tetherless insufflation in colon capsule endoscopy
|
TW201412740A
(en)
|
2012-09-20 |
2014-04-01 |
Bayer Pharma AG |
Substituted pyrrolopyrimidinylamino-benzothiazolones
|
CN102871982B
(en)
|
2012-10-16 |
2014-09-10 |
中国科学院上海药物研究所 |
Medicine osmotic pump preparation
|
US10485409B2
(en)
|
2013-01-17 |
2019-11-26 |
Vanderbilt University |
Real-time pose and magnetic force detection for wireless magnetic capsule
|
US9687263B2
(en)
|
2013-05-30 |
2017-06-27 |
SinuSys Corporation |
Devices and methods for inserting a sinus dilator
|
WO2015027146A1
(en)
|
2013-08-22 |
2015-02-26 |
The General Hospital Corporation |
Inhibitors of human 12/15-lipoxygenase
|
WO2015191900A1
(en)
|
2014-06-12 |
2015-12-17 |
Ligand Pharmaceuticals, Inc. |
Glucagon antagonists
|
EP3190945A4
(en)
|
2014-09-09 |
2018-06-27 |
Vanderbilt University |
Hydro-jet endoscopic capsule and methods for gastric cancer screening in low resource settings
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
AU2016270984B2
(en)
|
2015-06-03 |
2021-02-25 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
PL3370705T3
(en)
|
2015-11-05 |
2022-08-01 |
The General Hospital Corporation |
Intrathecal delivery of nucleic acid sequences encoding abcd1 for treatment of adrenomyeloneuropathy
|
CN109310743A
(en)
|
2016-05-16 |
2019-02-05 |
因塔西亚制药公司 |
Glucagon receptor selectivity polypeptide and its application method
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
CA3040906A1
(en)
|
2016-10-20 |
2018-04-26 |
Peptron, Inc. |
Methods of delivering a neuroprotective polypeptide to the central nervous system
|
EP3565580B1
(en)
|
2017-01-03 |
2024-03-06 |
i2o Therapeutics, Inc. |
Continuous administration of exenatide and co-adminstration of acetaminophen, ethinylestradiol or levonorgestrel
|
US20200188479A1
(en)
|
2017-03-08 |
2020-06-18 |
Intarcia Therapeutics, Inc. |
Apparatus and methods for administration of a nauseogenic compound from a drug delivery device
|
US11122965B2
(en)
|
2017-10-09 |
2021-09-21 |
Vanderbilt University |
Robotic capsule system with magnetic actuation and localization
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
AU2019357621A1
(en)
|
2018-10-11 |
2021-05-27 |
Intarcia Therapeutics, Inc. |
Human amylin analog polypeptides and methods of use
|
US20200155466A1
(en)
*
|
2018-11-21 |
2020-05-21 |
II Don S. Houtz |
Oral Medicine Delivery Capsule
|
CN109589491B
(en)
*
|
2019-01-29 |
2024-01-09 |
上海安翰医疗技术有限公司 |
Automatic drug delivery device
|
KR20220140711A
(en)
|
2020-01-13 |
2022-10-18 |
듀렉트 코퍼레이션 |
Reduced Impurity Sustained Release Drug Delivery Systems and Related Methods
|